|

|

close search icon

Company Profile

Corporate Culture

Management Team

Company History

Message from the CEO

Honors and Awards

Over 19 years of experience in R&D

01 Drug Discovery

Chemistry Research

Catalyst Screening

Enzyme Catalysis

Medicinal Chemistry

Synthetic Chemistry

Analytical Chemistry

Full Time Equivalent(FTE)

Fee For Service(FFS)

Biology Research

Structural Biology

Enzymology & Molecular Interactions

Antibody Discovery

Translational Medicine

Computational Biology & Molecular Modeling

Early Pharmacokinetics

Radiolabel ADME

02 Pharmaceutical Research

Active Pharmaceutical Ingredients

Route Selection

Production Process Optimization

Clinical Sample Production

Impurity Traceability & Control

Generic Drug Process Study & Filing

Innovative Drug Process Study & Filing

Pharmaceutical preparation

Consistency Evaluation

Preformulation Study

Formulation Stability Study

GMP-based Clinical Sample Production & Packaging

Pilot-scale Preparation Testing

Laboratory-scale Preparation Testing

Preparation Quality Research

Formulation Technology Research

Analytical Method Development and Quality Control

03 Preclinical Research

Pharmacology & Pharmacodynamics

Digestive System Disease Models

Endocrine & Metabolic Disease Models

Inflammatory & Immune Diseases Models

Neural System Disease Models

Other Disease Models

Ocular Diseases Models

Cardiovascular Model

Drug Safety Evaluation

Pharmacology & Toxicology Study

Safety Pharmacology

Histopathological Study

Clinicopathological Study

Drug Safety Evaluation Basic Information

In Vitro ADME Assays

In Vivo Pharmacokinetic Assays

Macromolecular Drugs Bioanalysis

Micromolecular Drugs Bioanalysis

01 One-stop Integrated Services

Drug Discovery Platform

Pharmaceutical Research Platform

Preclinical Research Services

Chemical Drug Development

One-stop API Process R&D Department

Medicilon's CDMO Service Platform

Pharmaceutical Research CDMO Service Platform

Translational Medicine Platform

GLP-1 New Drug R&D Service

Botanical Drug Preclinical R&D Technology Platform

02 Innovative Drug Services

ADC R&D Service Platform

PROTAC R&D Service Platform

mRNA Vaccine Bioanalysis Platform

Non-clinical Research for Cellular Immunotherapies

Nucleic Acid Drug R&D Platform

03 Key Technical Services for Drug R&D

Cytokine and Biomarker Detection Platform

Metabolite Identification (MetID) Service Platform

Drug Forming Research Platform

Safety Assessment Lab of Process Chemistry

Flow Cytometry Technology Platform

SEND Format Conversion Platform

Process Department Solid Form Screening Platform

Green Chemistry Platform

Flow Sorting Platform

NanoString nCounter Detection Platform

04 Drug Efficacy Evaluation for Common Diseases

IO Pharmacodynamic Model Evaluation Platform

Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases

Rodent Cerebrovascular Disease Drug Efficacy Evaluation System

05 Advanced Preparation R&D

Inhalation drug R&D platform

Ophthalmic drug R&D platform

Skin Topical Preparation R&D

06 Drug Analysis

07 Public Services

Intellectual Property Protection

Clients Testimonials

Medicilon Support

U.S.

Address: 50 Soldiers Field Place, Boston, MA 02135 (America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Medicilon Events

Featured Stories

2023-07-27Medicilon Events

The Medicilon DMPK team was praised again, and Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award

Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award the Medicilon DMPK team the "Best Partner Award" to express their gratitude and recognition.

2023-07-27Medicilon Events

Fudan University, School of Management "Science and Technology Entrepreneur Camp" entered Medicilon: "Hardcore Technology" as the background color, Adding "luster" to new drug research and development

On July 14, Professor Xiongwen Lu, Dean of the School of Management of Fudan University, led the professor group of Fudan School of Management and the students of the fifth phase of the Fudan Science and Technology Entrepreneur Camp into the Zhangjiang Park of Shanghai Medicilon Inc. (Medicilon) to conduct a site visit.

Stock Information

Investment Contact

Medicilon 688202

RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

Talent Development

Employee Activities

Campus Recruitment

Social Recruitment

Campus Recruitment

Campus Recruitment

Social Recruitment

Social Recruitment

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

ABOUT
Company Profile Management Team Honors and Awards Corporate Culture

SERVICES
Drug Discovery Pharmaceutical Research Preclinical Research

PLATFORM
One-stop Integrated Services Innovative Drug R&D Services Key Technical Services for Drug R&D Drug Efficacy Evaluation for Common Diseases High-end Preparations Technology Platform Public Services

CLIENT CENTER
Intellectual Property Protection Clients Testimonials Downloads Partnerships Medicilon Support Newsletters

NEWS
Medicilon Events Featured Stories Market Events Videos A.C.E.

INVESTORS
Stock Information Investment Contact

CAREERS
Talent Development Employee Activities Campus Recruitment Social Recruitment

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 |Website Map

关闭

Contact Us

Business Inquiry

Global：

Email:marketing@medicilon.com

+1(626)986-9880(U.S.)

0044 7790 816 954 (Europe)

China：

Email: marketing@medicilon.com.cn

Tel: +86 (21) 5859-1500

Message

Back To Top

Online Message×

Medicilon's News and Events

News and Events

Medicilon Events Featured Stories Market Events Videos A.C.E.

News and Events

Hot information：

Top 10 Global CDMO Enterprises| Top 10 Global Clinical Research Organizations in 2021| Preclinical Drug Development Process|

Medicilon Events

More

2023-07-27 ·Medicilon Events

The Medicilon DMPK team was praised again, and Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award

Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award the Medicilon DMPK team the "Best Partner Award" to express their gratitude and recognition.

More

2023-07-27 ·Medicilon Events

Fudan University, School of Management "Science and Technology Entrepreneur Camp" entered Medicilon: "Hardcore Technology" as the background color, Adding "luster" to new drug research and development

On July 14, Professor Xiongwen Lu, Dean of the School of Management of Fudan University, led the professor group of Fudan School of Management and the students of the fifth phase of the Fudan Science and Technology Entrepreneur Camp into the Zhangjiang Park of Shanghai Medicilon Inc. (Medicilon) to conduct a site visit.

More

2023-07-14 ·Medicilon Events

Another honor! Medicilon won the "Top 50 Chinese Pharmaceutical R&D" in 2022-2023

The press conference released the most influential list of China's pharmaceutical industry in 2022-2023. Medicilon once again won the "Top 50 Chinese Pharmaceutical R&D" in 2022-2023 based on its comprehensive strength.

More

2023-09-20 ·Medicilon Events

Medicilon's Interview: See how Dr. Chen Chen from ABM Therapeutics crosses the blood-brain barrier

Shanghai Medicilon Inc. (Medicilon) has the honor to invite Dr. Chen Chen, Founder and Chairman of ABM Therapeutics, to discuss the unique technical advantages and R&D strategies of ABM Therapeutics in developing brain-targeted drugs, as well as the inner journey and profound insights.

2023-08-14 ·Medicilon Events

Medicilon was selected into the SSE Science and Technology Innovation Board 100 Index, R&D intensity and revenue growth have been recognized

On August 7, 2023, the Shanghai Stock Exchange officially launched the SSE Science and Technology Innovation Board 100 Index. Shanghai Medicilon Inc. was selected as one of the SSE Science and Technology Innovation Board 100 Index.

2023-07-31 ·Medicilon Events

Medicilon interview with Dr. Xin Dong - In the field of immunotherapy, where the fierce competition is in full swing, where does Neologics Bioscience come from?

Medicilon interviewed Dr. Xin Dong to get a glimpse of his profound insights in the field of immunotherapy, and "learn from the experience" to grow in the era of new drugs.

2023-07-28 ·Medicilon Events

Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together

On July 25, 2023, Fosun Health Capital established by Fosun Pharma（stock code:600196.SH), reached a strategic partnership with Medicilon（stock code: 688202.SH).

2023-07-27 ·Medicilon Events

The Medicilon DMPK team was praised again, and Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award

Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award the Medicilon DMPK team the "Best Partner Award" to express their gratitude and recognition.

2023-07-27 ·Medicilon Events

Fudan University, School of Management "Science and Technology Entrepreneur Camp" entered Medicilon: "Hardcore Technology" as the background color, Adding "luster" to new drug research and development

On July 14, Professor Xiongwen Lu, Dean of the School of Management of Fudan University, led the professor group of Fudan School of Management and the students of the fifth phase of the Fudan Science and Technology Entrepreneur Camp into the Zhangjiang Park of Shanghai Medicilon Inc. (Medicilon) to conduct a site visit.

2023-07-14 ·Medicilon Events

Another honor! Medicilon won the "Top 50 Chinese Pharmaceutical R&D" in 2022-2023

The press conference released the most influential list of China's pharmaceutical industry in 2022-2023. Medicilon once again won the "Top 50 Chinese Pharmaceutical R&D" in 2022-2023 based on its comprehensive strength.

2023-07-12 ·Medicilon Events

Medicilon topped the "Top 10 Most Influential CRO Enterprises" in the 2023 China Biopharmaceutical Industry Value List

The 9th BIO-PHARM2023 and the 2023 China Biopharmaceutical Industry Value List Awards Ceremony were grandly opened in Suzhou. Medicilon was listed in the "Top 10 Most Influential CRO Enterprises".

2023-07-12 ·Medicilon Events

Medicilon and EyeCure reached a strategic collaboration to facilitate the preclinical research and development of ophthalmic cell and gene drugs

Recently, Shanghai Medicilon Inc. (Medicilon) and EyeCure reached a strategic collaboration. The two parties will carry out comprehensive collaboration in the field of ophthalmic cell and gene therapy.

Featured Stories

More

Medicilon's GLP-1 New Drug R&D Service

Medicilon's GLP-1 New Drug R&D Service

Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates

Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates

Medicilon Flow Sorting Platform

Medicilon Flow Sorting Platform

More

Market Events

More

Medicilon will exhibit in the AACR-NCI-EORTC International Conference

Join Medicilon at the 13th DRUG DISCOVERY Strategic Summit

Join Medicilon at the 2023 SAPA Annual Conference & 30-Year Anniversary Celebration

Join Medicilon at the 21st San Diego Biopharma Conference (SABPA 2023)

More

Video

More

Physiological Actions of GLP-1s

2023 Medicilon Semi-annual Report

Introduction of GLP-1s

Global

Address: 50 Soldiers Field Place, Boston, MA 02135 (America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

Address: 5th Floor, 24, Seochojungang-ro 8-gril, Seocho-gu, Seoul, 06643 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy

-->